News From Industry Sources
Innovative cannabis derived treatment option for cancer pain now available in Canada
August 7, 2007
Health Canada has approved SATIVEX(R), a cannabis derived pharmaceutical treatment, as adjunctive analgesic treatment in adult patients with advanced cancer who experience moderate to severe pain during the highest tolerated dose of strong opioid therapy for persistent background pain Story
Breakthrough botanical for joint pain
July 26, 2007
The shea nut is making inroads as a proven way to combat inflammation and joint pain, naturally. The inflammation reducing properties of shea nut compounds called triterpenes make it the most powerful inflammation fighter of any known botanical. Story
Health Canada expands use of new COX-2 inhibitor
July 25, 2007
Novartis Pharmaceuticals Canada Inc.
announced today the expanded Health Canada approval of Prexige(*) (lumiracoxib) for the acute and chronic treatment of the signs and symptoms of osteoarthritis (OA) in adults. Story
FDA approves first of a kind medical device to treat cervical degenerative disc disease
July 17, 2007
The U.S. Food and Drug Administration (FDA) approved for marketing the Prestige Cervical Disc, made by Medtronic Sofamor Danek of Memphis—the first artificial cervical (neck) disc for the treatment of cervical degenerative disc disease, one of the most common causes of neck and arm pain. Story
|
